Sudeep Pharma IPO Will Open On Nov 21, 2025 and Close On Nov 25, 2025. The ₹895.00 Cr. IPO is A Book Build Issue, Consisting Entirely of Fresh Offer and Offer for Sale. Sudeep Pharma IPO Price Band Is Set At ₹563 to ₹593 Per Share.
The Allotment will Be Finalized On Nov 26, 2025 and Listing date is Expected on The NSE BSE By Nov 28, 2025. Investor Quota like 50% QIB, 35% Retail, and 15% HNI Category.
Financial Year 2025 Company Posted a Total income 511.33 Cr. and A Net Profit of ₹138.69 Cr. Showing Strong Growth From The Previous Year. Based On Financial, The IPO Looks Promising For Long-term Investors.
Sudeep Pharma IPO Details
| Open Date | Nov 21, 2025 |
|---|---|
| Close Date | Nov 25, 2025 |
| Price Band | ₹563 to ₹593 per share |
| Face Value | ₹1 per equity share |
| Lot Size | 25 Shares |
| Type of Issue | Fresh Issue Cum OFS |
| Total Issue Size | 1,50,92,750 shares (Approx ₹895.00 Cr) |
| Fresh Issue | 16,02,024 shares (Approx ₹95.00 Cr) |
| Offer For Sale | 1,34,90,726 shares (Approx ₹800.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing Exchange | BSE & NSE |
| Retail Investor Quota | 35.00% |
| NII (HNI) Quota | 15.00% |
| QIB Quota | 50.00% |
| Anchor Investor List | Click Here |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
About Sudeep Pharma Limited
Our Company was originally incorporated on December 21, 1989 as “Sudeep Pharma Limited” We are a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem.
We leverage our inhouse developed technologies for processes such as encapsulation, spray drying, granulation, trituration, liposomal preparations and blending in an effort to drive innovation in our operations. We have established a presence in both, domestic and international markets, including key regions such as the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
Our business is Primarily Structured into Two Verticals:
Pharmaceutical Food and Nutrition. We focus on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries. Our product portfolio includes key mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper.
Specialty Ingredients. We conduct this business through our Subsidiary, SNPL and are committed to developing technology-driven, application-specific mineral and micronutrient systems.
We have served over 1,100 Customers, and have built longstanding relationships with Marquee Customers including Pfizer Inc, Intas Pharmaceuticals Limited, Mankind Pharma Limited, Merck Group, Alembic Pharmaceutical Limited, Aurobindo Pharma Limited, Cadila Pharmaceutical Limited, IMCD Asia Pte. Ltd., Micro Labs Limited, and Danone S.A. Our Largest customer.
Our Competitive Strengths
- Market leadership with a diversified product portfolio in a high barrier industry.
- Distinguished global customer base with long-standing relationships with key customers.
- Well-equipped and regulatory compliant Manufacturing Facilities.
- Strong research and development capabilities.
- Experienced Promoters and senior management team.
Sudeep Pharma IPO Market Lot Size
The Minimum Lot Size For The Sudeep Pharma IPO is 25 Shares, Requiring An Application Amount of ₹14,825 For Retail Investors. Investors Must Apply in Multiples of The Lot Size.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 25 | ₹14,825 |
| Retail Maximum | 13 | 325 | ₹1,92,725 |
| S-HNI Minimum | 14 | 350 | ₹2,07,550 |
| S-HNI Maxmum | 67 | 1,675 | ₹9,93,275 |
| B-HNI Minimum | 68 | 1,700 | ₹10,08,100 |
Sudeep Pharma IPO Dates
Sudeep Pharma IPO Will Open on Nov 21, and Close on Nov 25, 2025. The allotment is Expected on Nov 26, With the Listing Scheduled on NSE BSE For Nov 28, 2025 (More information below table).
| IPO Open | Fri, Nov 21, 2025 |
|---|---|
| IPO Close | Tue, Nov 25, 2025 |
| Allotment Finalisation | Wed, Nov 26, 2025 |
| Refunds / Unblocking | Thu, Nov 27, 2025 |
| Shares Credited to Demat | Thu, Nov 27, 2025 |
| Listing Date | Fri, Nov 28, 2025 |
Sudeep Pharma IPO Financial Report (FY 2025)
Sudeep Pharma Reported a Total Income of ₹511.33 Cr. in FY 2025, Slightly up From ₹438.26 Cr. in FY 2024. The Company Net Profit Also Rose to ₹138.69 Cr. From ₹133.15 Cr. in the Previous Year Showing Consistent Financial Growth Ahead of its IPO. (More information below table).
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 922.26 | 717.17 | 513.87 | 420.11 |
| Total Income | 130.08 | 511.33 | 465.38 | 438.26 |
| Profit After Tax | 31.27 | 138.69 | 133.15 | 62.32 |
| EBITDA | 48.57 | 199.28 | 187.76 | 98.64 |
| NET Worth | 688.32 | 497.53 | 359.07 | 226.29 |
| Reserves and Surplus | 668.52 | 481.11 | 354.59 | 221.88 |
| Total Borrowing | 135.97 | 135.25 | 75.03 | 82.26 |
| Amount in ₹ Crore |
Sudeep Pharma IPO Valuation (KPI 2025)
Check Detailed Sudeep Pharma IPO Valuation Metrics for FY 2025, including EPS, P/E Ratio, RoNW, NAV, ROCE, and other key financial indicators. These Ratios help Investors Assess the Company financial Health & Valuation Before applying for The IPO. (More information below table).
| KPI | Value |
|---|---|
| EBITDA Margin | 39.70% |
| PAT Margin | 27.63% |
| Debt-to-Equity Ratio | 0.20 |
| Earnings Per Share (EPS) | 11.44 |
| Price to Earnings Ratio (P/E) | 53.55 |
| Return on Net Worth (RoNW) | 27.88% |
| Net Asset Value (NAV) | 45.86 |
Objects of Issue
- Capital expenditure towards procurement of machinery for our production line located at Nandesari FacilityI.
- General corporate purposes.
Our Company Promoters
- Sujit Jaysukh Bhayani
- Shanil Sujit Bhayani
- Avani Sujit Bhayani
- Sujeet Jaysukh Bhayani HUF
- Riva Resources Private Limited
- Bhayani Family Trust
Sudeep Pharma Comparison With Industry Peers
There are no peer group companies listed in India which are in the same line of business as our Company.
Also Read: Capillary Technologies IPO GMP, Price, Date, Review, Details
Sudeep Pharma Company Contact Details
Office: 1-B, Hootagalli Industrial Area,
Mysore – 570018 Karnataka, India;
Telephone: +91 821 428 2247
Tel: +91 821 428 2247,
E-mail: ipo@excelsoftcorp.com
Website: www.excelsoftcorp.com
Sudeep Pharma Lead Manager
ICICI Securities Limited
ICICI Venture House,
Appasaheb Marathe Marg Prabhadevi Mumbai 400 025,
Maharashtra, India
Tel.: +91 22 6807 7100
E-mail:sudeep.ipo@icicisecurities.com
IIFL Capital Services Limited
24th Floor, One Lodha Place Senapati Bapat Marg Lower Parel (West),
Mumbai 400 013 Maharashtra, India
Tel: +91 22 4646 4728
E-mail: sudeep.ipo@iiflcap.com
Sudeep Pharma IPO Registrar
MUFG INTIME INDIA PRIVATE LIMITED
C-101, Embassy 247, L B S Marg,
Vikhroli (West), Mumbai-400 083
Maharashtra, India
Tel: +91 810 811 4949
E-mail: excelsofttechnologies.ipo@linkintime.co.in
Website: www.linkintime.co.in
Sudeep Pharma IPO FAQs
Question 1: What is the Sudeep Pharma IPO?
Answer 1: Sudeep Pharma IPO is a Mainboard IPO of 1,50,92,750 equity shares of the face value of ₹1 approximately up to ₹895.00 Cr. The issue is price at ₹563 to ₹593 per share.
The Sudeep Pharma IPO opens on 21, Nov 2025 and closes on 25, Nov 2025.
MUFG Intime India Private Limited is the registrar for the IPO. The shares to be listed on NSE BSE.
Question 2: How to apply in Sudeep Pharma IPO through Groww?
Answer 2: Groww customers can apply online in Sudeep Pharma IPO using UPI as a payment gateway. Groww customers can apply in Sudeep Pharma IPO by login into Groww (back office) and submitting an IPO application form.
Steps to apply in Sudeep Pharma IPO through Groww –
- Visit the Groww website and login to Groww.
- Go to Main Page and click the Products & tools and click IPO tab.
- New page Open and Show ‘ Sudeep Pharma IPO’ click the ‘Apply’ button.
- Show IPO detail Shares lot Size and Bid Price & click here to Cutoff Price check Box and Continue.
- Inter Your UPI id like . 95****2992@kotak accept terms and condition click Box and Apply For IPO
- groww share payment link Your UPI Mobile Number Pay Payment for IPO Bid to approve the e-mandate successfully submit application .
Question 3: When Sudeep Pharma IPO will open?
Answer 3: The Sudeep Pharma IPO opens on Nov 21, 2025 and closes on Nov 25, 2025.
Question 4: What is the lot size of Sudeep Pharma IPO?
Answer 4: Sudeep Pharma IPO lot size and the minimum order quantity is 25 Shares.
Question 5: How to apply for Sudeep Pharma IPO?
Answer 5: You can apply in Sudeep Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Groww, Zerodha, Upstox, 5Paisa, Phonepe Share Market, HDFC Bank, and Angel one.
Question 6: When is Sudeep Pharma IPO allotment date?
Answer 6: The Basis of Allotment for Sudeep Pharma IPO will be on Mon, Nov 26, 2025, and the allotted shares will be credited to your demat account by, Tue, Nov 27, 2025. For Check the Sudeep Pharma IPO allotment status.
Question 7: When is Sudeep Pharma IPO listing date?
Answer 7: The Sudeep Pharma IPO listing date is Nov 27, 2025. The date of Sudeep Pharma IPO listing on Wed, Nov 28, 2025.
